Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 427

Sort by

Sort Order Select

Journal Articles

Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged Leukemia

Blood blood.2024026928.

https://doi.org/10.1182/blood.2024026928

Published: 2025

Includes: Supplemental data

Journal Articles

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infection

Blood (2025) 146 (19): 2336–2349.

https://doi.org/10.1182/blood.2024026805

Published: 2025

Includes: Supplemental data

Journal Articles

Bone marrow environmental alterations underlie proliferative clonal expansion in clonal hematopoiesis

Masahiro Nakagawa, Ryosaku Inagaki, Yasuhito Nannya, Masanori Motomura, Ryunosuke Saiki, Yotaro Ochi, Ayana Kon, Lanying Zhao, Koji Okazaki, Xingxing Qi, Akinori Yoda, Nobuyuki Kakiuchi, Shuichi Matsuda, Seishi Ogawa

Blood (2025) 146 (Supplement 1): 632.

https://doi.org/10.1182/blood-2025-632

Published: 2025

Journal Articles

Clonal evolution and therapeutic vulnerabilities in SETBP1-mutated leukemia: Insights from physiological mouse model and integrative functional screens

Blood (2025) 146 (Supplement 1): 989.

https://doi.org/10.1182/blood-2025-989

Published: 2025

Journal Articles

Whole-genome analysis reveals shared early genetic alterations and subtype-specific immune evasion pathways in intravascular large B-cell lymphoma and immune-privileged large B-cell lymphoma

Takuto Mori, Kazuyuki Shimada, Kaito Mimura, Suguru Fukuhara, Koji Izutsu, Daisuke Kawauchi, Yoshitaka Narita, Akiko Miyagi Maeshima, Ryosuke Koyamada, Nobuhiro Hiramoto, Nobuyuki Kakiuchi, Hirona Maeda, Ai Okada, Kenichi Chiba, Yuichi Shiraishi, Akifumi Takaori-Kondo, Seishi Ogawa, Akihiro Tomita, Kenichi Yoshida

Blood (2025) 146 (Supplement 1): 7061.

https://doi.org/10.1182/blood-2025-7061

Published: 2025

Journal Articles

The prognostic significance (or lack) of achieving marrow complete remission (mCR) with hypomethylating agent-based therapy in patients with myelodysplastic syndrome

Benjamin Rolles, Jan Philipp Bewersdorf, Tariq Kewan, Ondrej Blaha, Jessica Stempel, Luca Lanino, Najla Al Ali, Amy DeZern, Mikkael Sekeres, Geoffrey Uy, Samuel Urrutia, Hetty Carraway, Pinkal Desai, Elizabeth Griffiths, Eytan Stein, Andrew Brunner, Christine McMahon, Rory Shallis, Joshua Zeidner, Michael Savona, Namrata Chandhok, Constantine Logothetis, Aram Bidikian, Theodore Getz, Gail Roboz, Eunice Wang, Maria Amaya, Hayley Hawkins, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan Madanat, Yasmin Abaza, Talha Badar, Jaclynn Campos, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop Enjeti, Kamal Alrabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Matteo Della Porta, Rami Komrokji, Amer Zeidan, Maximilian Stahl

Blood (2025) 146 (Supplement 1): 3865.

https://doi.org/10.1182/blood-2025-3865

Published: 2025

Journal Articles

Clinical implications of TP53 mutations (TP53MT) in patients (pts) with higher risk Myelodysplastic Syndromes (HR-MDS) treated with hypomethylating agents (HMA) and allogeneic hematopoietic transplantation (allo-HCT): An analysis from the international consortium of MDS (icMDS) validate database

Tariq Kewan, Jan Philipp Bewersdorf, Luca Lanino, Ondrej Blaha, Jessica Stempel, Najla Al Ali, Amy DeZern, Mikkael Sekeres, Geoffrey Uy, Samuel Urrutia, Hetty Carraway, Pinkal Desai, Elizabeth Griffiths, Eytan Stein, Andrew Brunner, Christine McMahon, Rory Shallis, Joshua Zeidner, Michael Savona, Namrata Chandhok, Constantine Logothetis, Aram Bidikian, Theodore Getz, Gail Roboz, Benjamin Rolles, Eunice Wang, Amyah Harris, Maria Amaya, Hayley Hawkins, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan Madanat, Yasmin Abaza, Talha Badar, Jaclynn Campos, Torsten Haferlach, Jaroslaw Maciejewski, Anoop Enjeti, Kamal Al-Rabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Rami Komrokji, Maximilian Stahl, Matteo Della Porta, David Sallman, Amer Zeidan

Blood (2025) 146 (Supplement 1): 3863.

https://doi.org/10.1182/blood-2025-3863

Published: 2025

Journal Articles

Comparative evaluation of ipss-m and cpss-mol in CMML: Impact of molecular markers on prognosis

Alexander Streuer, Yotaro Ochi, Yasuhito Nannya, Laurenz Steiner, Vladimir Riabov, Mohammed Abba, Eva Altrock, Felicitas Rapp, Verena Nowak, Georgia Metzgeroth, Seishi Ogawa, Wolf-Karsten Hofmann, Nanni Schmitt

Blood (2025) 146 (Supplement 1): 3860.

https://doi.org/10.1182/blood-2025-3860

Published: 2025

Journal Articles

Functional classification of monoallelic TP53 mutations refines prognostic stratification in myelodysplastic neoplasms

Alexander Streuer, Vladimir Riabov, Yotaro Ochi, Yasuhito Nannya, Laurenz Steiner, Mohammed Abba, Georgia Metzgeroth, Eva Altrock, Felicitas Rapp, Verena Nowak, Daniel Nowak, Seishi Ogawa, Wolf-Karsten Hofmann, Nanni Schmitt

Blood (2025) 146 (Supplement 1): 3835.

https://doi.org/10.1182/blood-2025-3835

Published: 2025

Journal Articles

Single-cell multiomic profiling of gene mutation, chromatin accessibility, and gene expression in TET2-mutant clonal hematopoiesis

Masanori Motomura, Yotaro Ochi, Yasuhito Nannya, Nobuyuki Kakiuchi, Nobuo Sezaki, Senji Kasahara, Tomoe Nakagawa, Lanying Zhao, Shuichi Matsuda, Masahiro Nakagawa, Seishi Ogawa

Blood (2025) 146 (Supplement 1): 3164.

https://doi.org/10.1182/blood-2025-3164

Published: 2025

Journal Articles

Repertoire of driver events in coding and non-coding regions identified by whole-genome sequencing of myeloid neoplasms

Blood (2025) 146 (Supplement 1): 1450.

https://doi.org/10.1182/blood-2025-1450

Published: 2025

Journal Articles

Transcriptional and splicing dysregulation by U2AF1 mutations contribute to inflammatory and migratory alterations in MDS

Yuki Hodo, Azumi Tomita, Xingxing Qi, Manabu Nakayama, Haruhiko Koseki, Yasuhito Nannya, Seishi Ogawa, Ayana Kon

Blood (2025) 146 (Supplement 1): 5018.

https://doi.org/10.1182/blood-2025-5018

Published: 2025

Journal Articles

Single-cell multi-omics uncovers differentiation-dependent transcriptional programs shaping epigenetic subgroups in AML

Blood (2025) 146 (Supplement 1): 5005.

https://doi.org/10.1182/blood-2025-5005

Published: 2025

Journal Articles

SLF2 and SMC5 are novel causative genes for inherited bone marrow failure syndromes, driving HSC aging and predisposing to MDS

Sho Shibata, Kazuhisa Chonabayashi, Hirofumi Nakamura, Akitsu Hotta, Yuri Uchiyama, Yukiko Oh, Naomichi Matsumoto, Yotaro Ochi, Seishi Ogawa, Akifumi Takaori-Kondo, Yoshinori Yoshida

Blood (2025) 146 (Supplement 1): 4989.

https://doi.org/10.1182/blood-2025-4989

Published: 2025

Journal Articles

DNA methylation profiling identifies two epigenetic subgroups with prognostic implications in pediatric acute promyelocytic leukemia: The JCCG study, JPLSG AML-P05

Etsuko Murayama, Tomoko Kawai, Genki Yamato, Norio Shiba, Kentaro Ohki, Yusuke Hara, Taeko Kaburagi, Takumi Takizawa, Hirohide Kawasaki, Kenichi Yoshida, Daisuke Tomizawa, Takashi Taga, Souichi Adachi, Yuki Yuza, Hiroyuki Takahashi, Seishi Ogawa, Yasuhide Hayashi

Blood (2025) 146 (Supplement 1): 3474.

https://doi.org/10.1182/blood-2025-3474

Published: 2025

Journal Articles

Genetic landscape of pediatric myelodysplastic syndrome in Japan

Masataka Hasegawa, Kaito Mimura, Rintaro Ono, Dai Keino, Shin-Ichi Tsujimoto, Kiyotaka Isobe, Takao Deguchi, Hideto Iwafuchi, Hiroshi Moritake, Hironori Goto, Atsushi Manabe, Seishi Ogawa, Kenichi Yoshida, Daisuke Hasegawa

Blood (2025) 146 (Supplement 1): 5612.

https://doi.org/10.1182/blood-2025-5612

Published: 2025

Journal Articles

Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database

Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, Wei Wei, Najla Al Ali, Amy DeZern, Mikkael Sekeres, Geoffrey Uy, Samuel Urrutia, Hetty Carraway, Pinkal Desai, Elizabeth Griffiths, Eytan Stein, Andrew Brunner, Christine McMahon, Rory Shallis, Joshua Zeidner, Michael Savona, Hayley Hawkins, Namrata Chandhok, Constantine Logothetis, Aram Bidikian, Theodore Getz, Gail Roboz, Benjamin Rolles, Eunice Wang, Amyah Harris, Maria Amaya, Somedeb Ball, Justin Grenet, Zhuoer Xie, Yazan Madanat, Yasmin Abaza, Jaclynn Campos, Talha Badar, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop Enjeti, Kamal Alrabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vassiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Max Stahl, Matteo Della Porta, Rami Komrokji, Amer Zeidan

Blood (2025) 146 (Supplement 1): 606.

https://doi.org/10.1182/blood-2025-606

Published: 2025

Journal Articles

Requirements for achievement of treatment-free remission in long-term survivor of multiple myeloma

Masataka Takeshita, Nobuyuki Kodama, Tomoko Hishima, Hiroshi Suzuki, Chigusa Kitayama, Risen Hirai, Akira Tanimura, Seishi Ogawa, Yasuhito Nannya, Akiyoshi Miwa

Blood (2025) 146 (Supplement 1): 7539.

https://doi.org/10.1182/blood-2025-7539

Published: 2025

Journal Articles

The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia

Yuichiro Semba, Takuji Yamauchi, Daniel E. Bauer, Seishi Ogawa, Koichi Akashi, Takahiro Maeda

Blood blood.2025028918.

https://doi.org/10.1182/blood.2025028918

Published: 2025

Includes: Supplemental data

Journal Articles

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery

Marco Roncador, Elsa Bernard, Robert Hasserjian, Jacqueline Boultwood, Chiara Elena, Anna Gallì, Carmelo Gurnari, Cristina Mecucci, Lucienne Michaux, Moshe Mittelman, Martina Sarchi, Erica Travaglino, Donal P. McLornan, Seishi Ogawa, Elli Papaemmanuil, Eva Hellström Lindberg, Luca Malcovati, Mario Cazzola

Blood (2025) 146 (16): 1883–1896.

https://doi.org/10.1182/blood.2025028619

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comprehensive Molecular and Functional Analysis of NUTM1-Rearranged Leukemia

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell–type chronic active EBV infection

Bone marrow environmental alterations underlie proliferative clonal expansion in clonal hematopoiesis

Clonal evolution and therapeutic vulnerabilities in SETBP1-mutated leukemia: Insights from physiological mouse model and integrative functional screens

Whole-genome analysis reveals shared early genetic alterations and subtype-specific immune evasion pathways in intravascular large B-cell lymphoma and immune-privileged large B-cell lymphoma

The prognostic significance (or lack) of achieving marrow complete remission (mCR) with hypomethylating agent-based therapy in patients with myelodysplastic syndrome

Clinical implications of TP53 mutations (TP53MT) in patients (pts) with higher risk Myelodysplastic Syndromes (HR-MDS) treated with hypomethylating agents (HMA) and allogeneic hematopoietic transplantation (allo-HCT): An analysis from the international consortium of MDS (icMDS) validate database

Comparative evaluation of ipss-m and cpss-mol in CMML: Impact of molecular markers on prognosis

Functional classification of monoallelic TP53 mutations refines prognostic stratification in myelodysplastic neoplasms

Single-cell multiomic profiling of gene mutation, chromatin accessibility, and gene expression in TET2-mutant clonal hematopoiesis

Repertoire of driver events in coding and non-coding regions identified by whole-genome sequencing of myeloid neoplasms

Transcriptional and splicing dysregulation by U2AF1 mutations contribute to inflammatory and migratory alterations in MDS

Single-cell multi-omics uncovers differentiation-dependent transcriptional programs shaping epigenetic subgroups in AML

SLF2 and SMC5 are novel causative genes for inherited bone marrow failure syndromes, driving HSC aging and predisposing to MDS

DNA methylation profiling identifies two epigenetic subgroups with prognostic implications in pediatric acute promyelocytic leukemia: The JCCG study, JPLSG AML-P05

Genetic landscape of pediatric myelodysplastic syndrome in Japan

Outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA) + venetoclax (VEN) – a large analysis from the international consortium for MDS (icMDS) validate database

Requirements for achievement of treatment-free remission in long-term survivor of multiple myeloma

The XPO7-NPAT axis represents key vulnerabilities in TP53-mutated acute myeloid leukemia

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only